Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Rosuvastatin 5 mg vs 10 mg in Hypercholesterolemia
NCT01613729Phase 4Unknown
- Sponsor
- D16 Pharma & Biotec
- Start
- Jul 2012
- Primary completion
- Jul 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in hypercholesterolemia, sponsored by D16 Pharma & Biotec. Status: unknown.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT01613729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01613729.